Palmoplantar pustulosis - Pustulosis Palmoplantarhttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Tha Pustulosis Palmoplantar (Palmoplantar pustulosis) na dhermatosis pustular leantainneach leantainneach (is e sin, pustulosis no psoriasis pustular) stèidhichte air na palms agus buinn a-mhàin, air a chomharrachadh gu h-eachdraidheil le pustules intraepidermal làn de neutrophils. Cleachdadh retinoids siostamach leotha fhèin agus ann an co-bhonn ri photochemotherapy gus comharran pustulosis palmoplantar (palmoplantar pustulosis) a leasachadh.

○ làimhseachadh
Tha acitretin beòil èifeachdach airson an seòrsa psoriasis seo.
#Acitretin
☆ Ann an toraidhean 2022 Stiftung Warentest às a’ Ghearmailt, cha robh sàsachd luchd-cleachdaidh le ModelDerm ach beagan nas ìsle na le co-chomhairlean telemedicine pàighte.
  • Anns a’ chùis seo, faodar pompholyx a bhith fo amharas cuideachd.
  • Às aonais pustules, faodar eczema làimhe a mheas mar dhearbhadh eadar-dhealaichte.
References Palmoplantar Psoriasis 28846363 
NIH
Is e seòrsa de psoriasis a th’ ann an Palmoplantar psoriasis a bheir buaidh mhòr air a’ chraiceann air na palms is buinn agad. Bidh e a’ nochdadh mar chraiceann tiugh le an dàrna cuid tioram, blistering, no measgachadh den dà sheòrsa.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).